American Radium Society Appropriate Use Criteria Report on Radiation in the Management of Ductal Carcinoma in Situ (DCIS) of the Breast

This publication has 47 references indexed in Scilit:

• Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ
  JAMA, 2025
• DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS
  Breast Cancer Research and Treatment, 2021
• Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients
  Clinical and Translational Oncology, 2019
• Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort
  Breast Cancer Research and Treatment, 2018
• Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies
  Breast Cancer Research and Treatment, 2018
• Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy
  JAMA Oncology, 2017
• A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone
  Breast Cancer Research and Treatment, 2015
• The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12‐gene DCIS score™ result
  Journal of Surgical Oncology, 2015
• Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04)
  Breast Cancer Research and Treatment, 2014
• Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study
  Breast Cancer Research and Treatment, 2013